Stock DC8A DURECT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News DURECT Corporation Deutsche Boerse AG

Equities

DC8A

US2666055007

Real-time Estimate Tradegate
Other stock markets
 12:14:11 2024-07-17 pm EDT 		5-day change 1st Jan Change
1.285 EUR +7.08% Intraday chart for DURECT Corporation +1.68% +130.48%
May. 21 DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis CI
May. 21 Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
CI
Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon
MT
Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment
MT
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
PR
Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says
MT
Transcript : DURECT Corporation, Q1 2024 Earnings Call, May 13, 2024
Durect: Q1 Earnings Snapshot
AQ
DURECT Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (DRRX) DURECT CORPORATION Reports Q1 Revenue $1.8M, vs. Street Est of $2.7M
MT
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
PR
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
PR
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
PR
Transcript : DURECT Corporation, Q4 2023 Earnings Call, Mar 27, 2024
Durect: Q4 Earnings Snapshot
AQ
DURECT Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (DRRX) DURECT CORPORATION Posts Q4 Revenue $2.7M, vs. Street Est of $2.7M
MT
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PR
DURECT Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Stocks Edge -2-
DJ
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRRX Stock
  4. DC8A Stock
  5. News DURECT Corporation